SCHEMBL5216552

SCHEMBL5216552

c1ccc(-n2cc(-c3cccc4ccccc34)cn2)nc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 11/20 0.69
▸ GRM5 P41594 1/20 0.52
▸ HTR2B P41595 1/20 0.47
▸ MTNR1A P48039 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ ALKBH2 Q6NS38 1/20 0.47
▸ EGLN1 Q9GZT9 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MET P08581 1/20 0.40
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5216817 0.86 GRM4 (0.87) GRM4GRM5HTR2BMTNR1AKCNH2
SCHEMBL5216821 0.79 GRM4 (0.60) GRM4GRM5HTR2BMTNR1AKCNH2
SCHEMBL5219316 0.76 GRM5 (0.61) GRM4GRM5ALKBH2EGLN1ADORA2A
SCHEMBL30796163 0.76 GRM5 (0.61) GRM4GRM5ALKBH2EGLN1ADORA2A
SCHEMBL5220686 0.75 GRM5 (0.60) GRM4GRM5ALKBH2EGLN1KDM4E
SCHEMBL5669713 0.75 GRM5 (0.71) GRM4GRM5ALKBH2EGLN1MAPT
SCHEMBL5222831 0.74 GRM4 (0.57) GRM4GRM5HTR2BMTNR1AKCNH2
SCHEMBL9465652 0.73 TNF (0.42) GRM4HTR2BMTNR1AKCNH2KDM4E
SCHEMBL5220880 0.73 GRM4 (0.56) GRM4GRM5ALKBH2EGLN1NPC1
SCHEMBL16534892 0.72 GRM4 (0.55) GRM4GRM5ALKBH2EGLN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 — — EP claimed
US-20050026963-A1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK SHARP & DOHME LLC 2005-02-03 — — US claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 — — WO claimed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 — — US disclosed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 — — US disclosed
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 — — EP disclosed
WO-2003051833-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026963-A1 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 GRM5, GRIK5, GRIN2C GRM4 8/4885GRM5 1/4885HTR2B 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback